Biz briefs

Job fair will be held at Fort Gordon today

A job fair will be held at Fort Gordon Army Reserve today from 9:30 a.m. to 2:30 p.m.

More than 45 employers, including General Dynamics, Sears, the FBI and the Fort Gordon Civilian Personnel Advisory Center, are scheduled to attend.

The first hour will be open only to Warriors in Transition , and the event will open to the public at 10:30 a.m.

The Reserve Center is in Building 14401, 15th and Lane streets.

Bank of America looks for emergency CEO

CHARLOTTE, N.C. — Bank of America Corp. plans to select an emergency CEO this week in case Ken Lewis steps down before the end of the year, the Wall Street Journal reported Monday.

Last week, the bank said Mr. Lewis plans to retire Dec. 31. Bank of America's board has created a six-member committee of directors to find his successor.

The planning for an emergency replacement for Mr. Lewis, who faces possible legal problems over the bank's acquisition of Merrill Lynch & Co., started before the bank announced his retirement, the Journal reported, citing a person familiar with the matter.

Coach's lawsuit says Target bags are copies

NEW YORK — Coach Inc. is suing low-price retailer Target Corp. over bags the luxury handbag maker says too closely resemble its own designs.

Coach wants Target to stop selling the bags and pay an undetermined amount in damages, injunctive relief and attorney fees, the New York-based company said in a complaint filed Thursday in U.S. District Court in Manhattan.

Coach also sued Minneapolis-based Target in 2006, claiming the retailer was selling a copy of one of its handbags. The companies settled the case.

"We are currently looking into this situation and working with our vendor partner," Target spokeswoman Jana O'Leary said .

Schering-Plough drug OK'd by FDA advisers

GAITHERSBURG, Md. — Federal health advisers voted 6-4 on Monday that the potential benefits of a Schering-Plough drug outweigh its toxic risks as a treatment for late-stage skin cancer.

The Food and Drug Administration often follows the panel's advice, though it isn't required to.

Schering-Plough has asked the FDA to approve its drug PegIntron for patients whose skin cancer has spread to their lymph nodes, requiring surgery. The drug is already approved as a treatment for hepatitis C.